Avience Biomedicals IPO
Upcoming SMEAlready have an account? Apply now
Avience Biomedicals IPO details
Schedule of Avience Biomedicals
| Issue open date | 18 Jun 2026 |
| Issue close date | 22 Jun 2026 |
| UPI mandate deadline | 22 Jun 2026 (5 PM) |
| Allotment finalization | 23 Jun 2026 |
| Refund initiation | 24 Jun 2026 |
| Share credit | 24 Jun 2026 |
| Listing date | 25 Jun 2026 |
| Mandate end date | 07 Jul 2026 |
| Lock-in end date for anchor investors (50%) | 22 Jul 2026 |
| Lock-in end date for anchor investors (remaining) | 20 Sep 2026 |
Note: The schedule is tentative. The anchor lock-in period ends 30 days after the actual allotment date for 50% of the shares and 90 days after for the remaining portion. The allotment status can be checked on the registrar's website and the exchange website.
About Avience Biomedicals
Avience Biomedicals Limited is an Indian healthcare products company engaged in the manufacturing and supply of diagnostic kits, medical devices and related healthcare products. The company began its operations with diagnostic solutions such as Viral Transport Media (VTM) and test kits for diseases including COVID-19, HIV, HBsAg, malaria and dengue. Over time, it expanded its portfolio to include in-vitro diagnostic (IVD) rapid test kits, serology products, biochemistry analysers and biochemistry reagents. The company serves the healthcare sector by providing products used in disease detection, diagnosis and laboratory testing. Its revenue is primarily generated through the sale of these diagnostic and medical device products. Avience Biomedicals operates in the medical devices and diagnostics segment and focuses on offering healthcare solutions across multiple testing and diagnostic categories.
Financials of Avience Biomedicals
Issue size
| Funds Raised in the IPO | Amount |
| Total issue size | 30.24 |
| Fresh Issue – Proceeds go to the company | 30.24 |
Utilisation of proceeds
| Purpose | INR crores (%) |
| Set up a new manufacturing unit at the YEIDA Medical Device Park, Gautam Buddha Nagar, Uttar Pradesh | 15.96 (52.78%) |
| Fund working capital requirements |
8.25 (27.28%) |
| General corporate purposes | 6.03 (20%) |
Strengths
- Manufactures a wide range of diagnostic kits, medical devices, analysers and reagents.
- Serves pathology labs, hospitals, research centres and other healthcare institutions.
- Holds ISO 9001, ISO 13485, GMP and ZED MSME Gold certifications.
- Operates a manufacturing facility in Noida with advanced processing capabilities.
- Has expanded from diagnostic kits to a broader portfolio of healthcare products.
Risks
- Business performance may be affected by changes in government policies and regulations.
- Operations depend on the continued services of key management personnel and employees.
- The company relies on third-party transportation and logistics providers.
- Market demand and industry fluctuations can impact revenue and profitability.
- The company has ongoing legal proceedings involving commercial and cheque dishonour matters.